Dossier
BioOrbit
Coverage of BioOrbit in the Nexus archive.
- Final frontier for meds? UK startup sends drug-making into space
A UK startup, BioOrbit, launched a drug-crystallisation technology unit called Box-E to the International Space Station via SpaceX to grow ultra-pure protein crystals. The goal is to develop self-injected cancer treatments that could save millions of lives.